Skip to main content

Advertisement

Table 2 Characteristics of the seven patients with malignant tumors

From: Biodistribution and radiation dosimetry of the novel hypoxia PET probe [18F]DiFA and comparison with [18F]FMISO

No. Age Sex Weight (kg) FMISO activity (MBq) DiFA activity (MBq) DiFA mass (μg) Diagnosis
1 68 M 65 394.2 703.1 0.338 Undifferentiated pleomorphic sarcoma
2 64 F 61 384.7 714.5 0.236 Small cell lung cancer
3 56 M 60 385.6 715.6 0.237 Rectal adenocarcinoma
4 63 F 51 374.6 725.2 0.277 Tongue squamous cell carcinoma
5 64 M 73 386.5 716.9 0.274 Liposarcoma
6 65 M 76 387.4 716.4 0.299 Hepatocellular carcinoma
7 48 F 52 386.5 733.3 0.306 Malignant melanoma
Mean 61.1 ± 6.3   62.6 ± 8.9 385.6 ± 5.4 717.9 ± 8.7 0.281 ± 0.034